Close

Yearly Archives: 2016

Optum & PAREXEL to Accelerate Drug Development, Reimbursement & Market Access with EHR-Fueled

Collaboration will focus on advancing drug development by combining clinical research and real-world evidenceOptum and PAREXEL International (NASDAQ:PRXL) formed a strategic alliance to reduce...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read